Cargando…

Targeted Vaccination against Human α-Lactalbumin for Immunotherapy and Primary Immunoprevention of Triple Negative Breast Cancer

We have proposed that safe and effective protection against the development of adult onset cancers may be achieved by vaccination against tissue-specific self-proteins that are “retired” from expression at immunogenic levels in normal tissues as we age, but are overexpressed in emerging tumors. α-La...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tuohy, Vincent K., Jaini, Ritika, Johnson, Justin M., Loya, Matthew G., Wilk, Dennis, Downs-Kelly, Erinn, Mazumder, Suparna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931621/ https://www.ncbi.nlm.nih.gov/pubmed/27322324 http://dx.doi.org/10.3390/cancers8060056

Ejemplares similares

Regulation of Murine Ovarian Epithelial Carcinoma by Vaccination against the Cytoplasmic Domain of Anti-Müllerian Hormone Receptor II
por: Sakalar, Cagri, et al.
Publicado: (2015)

Immunotherapeutic target expression on breast tumors can be amplified by hormone receptor antagonism: a novel strategy for enhancing efficacy of targeted immunotherapy
por: Jaini, Ritika, et al.
Publicado: (2017)

Advances in Nanotechnology for Cancer Immunoprevention and Immunotherapy: A Review
por: Koyande, Navami Prabhakar, et al.
Publicado: (2022)

Striking efficacy of a vaccine targeting TOP2A for triple-negative breast cancer immunoprevention
por: Lee, Sang Beom, et al.
Publicado: (2023)

Immunotherapy of ovarian cancer with a monoclonal antibody specific for the extracellular domain of anti-Müllerian hormone receptor II
por: Mazumder, Suparna, et al.
Publicado: (2020)

Correction: Immunotherapy of ovarian cancer with a monoclonal antibody specific for the extracellular domain of anti-Müllerian hormone receptor II
por: Mazumder, Suparna, et al.
Publicado: (2022)

Immunoprevention approaches for cancer prevention
por: Umar, Asad
Publicado: (2014)

Cancer Immunoprevention and Public Health
por: Singh, Sandeep K., et al.
Publicado: (2017)

Costs related to immunopreventable diseases: Brazil and its geographic areas (immunopreventable diseases’ costs in Brazil)
por: da Costa, Élide Sbardellotto M., et al.
Publicado: (2021)

A Novel Anti-PD-L1 Vaccine for Cancer Immunotherapy and Immunoprevention
por: Chen, Jie, et al.
Publicado: (2019)

An Overview of Cancer Prevention: Chemoprevention and Immunoprevention
por: Gu, Kyle J., et al.
Publicado: (2020)

Formulation of an ovarian cancer vaccine with the squalene-based AddaVax adjuvant inhibits the growth of murine epithelial ovarian carcinomas
por: Mazumder, Suparna, et al.
Publicado: (2022)

COVID-19: The Need for Immunoprevention at Industrial Scale
por: Halstead, Scott B.
Publicado: (2020)

Applications for α-lactalbumin in human nutrition
por: Layman, Donald K, et al.
Publicado: (2018)

Immunotherapy of pediatric brain tumor patients should include an immunoprevention strategy: a medical hypothesis paper
por: Driggers, Lara, et al.
Publicado: (2009)

Modelling vaccination schedules for a cancer immunoprevention vaccine
por: Motta, Santo, et al.
Publicado: (2005)

Cancer immunoprevention: from mice to early clinical trials
por: Palladini, Arianna, et al.
Publicado: (2018)

Vaccines for immunoprevention of DNA mismatch repair deficient cancers
por: Hernandez-Sanchez, Alejandro, et al.
Publicado: (2022)

α-Lactalbumin, Amazing Calcium-Binding Protein
por: Permyakov, Eugene A.
Publicado: (2020)

The influence of cations on α-lactalbumin amyloid aggregation
por: Antosova, Andrea, et al.
Publicado: (2022)

Immunoprevention of Basal Cell Carcinomas with Recombinant Hedgehog-interacting Protein
por: Vogt, Annika, et al.
Publicado: (2004)

Health Disparities in the Immunoprevention of Human Papillomavirus Infection and Associated Malignancies
por: Bakir, Amira H., et al.
Publicado: (2015)

Immunoprevention of KRAS-driven lung adenocarcinoma by a multipeptide vaccine
por: Pan, Jing, et al.
Publicado: (2017)

Hospital costs of immunopreventable diseases in the economically active population in Brazil
por: da Costa, Élide Sbardellotto M., et al.
Publicado: (2021)

Vaccination-Based Immunoprevention of Colorectal Tumors: A Primer for the Clinician
por: Jackson, Katy, et al.
Publicado: (2022)

Dynamic Surface Properties of α-Lactalbumin Fibril Dispersions
por: Noskov, Boris, et al.
Publicado: (2023)

Functionalization of Alpha-Lactalbumin by Zinc Ions
por: Gołębiowski, Adrian, et al.
Publicado: (2022)

Precision and Immunoprevention Strategies for Tobacco-Related Head and Neck Cancer Chemoprevention
por: Centuori, Sara M., et al.
Publicado: (2021)

Targeting Glutamine Metabolism to Enhance Immunoprevention of EGFR‐Driven Lung Cancer
por: Huang, Mofei, et al.
Publicado: (2022)

Multidrug Resistance in Cancer: Understanding Molecular Mechanisms, Immunoprevention and Therapeutic Approaches
por: Emran, Talha Bin, et al.
Publicado: (2022)

Vaccination with inhibin-α provides effective immunotherapy against testicular stromal cell tumors
por: Aguilar, Robert, et al.
Publicado: (2017)

Cancer Moonshot Immuno-Oncology Translational Network (IOTN): accelerating the clinical translation of basic discoveries for improving immunotherapy and immunoprevention of cancer
por: Annapragada, Ananth, et al.
Publicado: (2020)

Lynch syndrome cancer vaccines: A roadmap for the development of precision immunoprevention strategies
por: Sei, Shizuko, et al.
Publicado: (2023)

Effect of an α-lactalbumin-enriched infant formula with lower protein on growth
por: Trabulsi, J, et al.
Publicado: (2011)

Probing the urea dependence of residual structure in denatured human α-lactalbumin
por: Higman, Victoria A., et al.
Publicado: (2009)

Molecular Analytical Assessment of Thermally Precipitated α-Lactalbumin after Resolubilization
por: Haller, Nicole, et al.
Publicado: (2021)

Positive Effects of α-Lactalbumin in the Management of Symptoms of Polycystic Ovary Syndrome
por: Cardinale, Vincenzo, et al.
Publicado: (2022)

Immunotherapy for Triple-Negative Breast Cancer
por: Cao, Yifeng, et al.
Publicado: (2021)

Toxoplasma Rhoptries: Unique Secretory Organelles and Source of Promising Vaccine Proteins for Immunoprevention of Toxoplasmosis
por: Dlugonska, Henryka
Publicado: (2008)

Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis
por: Croci, Stefania, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_b0jmeqemd5r41e5ihb5e5k1m1f